Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study to Assess the Role of Selected Biomarkers in Subjects Requiring Daily Medium- to High-dose Inhaled Corticosteroids for Persistent Asthma

NCT01334853 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT01334853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01334853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study to Assess the Role of Selected Biomarkers in Subjects Requiring Daily Medium- to High-dose Inhaled Corticosteroids for Persistent Asthma
Lead sponsor
MedImmune LLC
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
September 30, 2012
Enrollment
97 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

asthma